Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Neha Krishnamohan

Director at Arcutis Biotherapeutics, Inc. (ARQT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $940K

Reported trades

Filed Stock Type Shares Price Value Since
Nov 17SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 39,27223,355 held (−63%) $23.19 $911K +24.3%
Nov 17SEC ARQTArcutis Biotherapeutics, Inc. Sell Plan 1,23222,123 held (−5%) $23.37 $29K +23.3%
  • Sell

    Director Neha Krishnamohan sold $911K of ARQT at $23.19 — cuts the stake by 63%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Neha Krishnamohan sold $29K of ARQT at $23.37 — pre-scheduled 10b5-1 plan sale.